Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAT-UP: Extended Antibiotic Treatment in Chronic UTI Patients
NCT07202949Phase 2Recruiting
- Sponsor
- University College London
- Start
- Feb 2026
- Primary completion
- Oct 2027
- Modality
- Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of cefalexin, nitrofurantoin, trimethoprim, methenamine hippurate in urinary tract infection (UTI), sponsored by University College London. Started Feb 2026; status: recruiting.
02
Drugs
cefalexinnitrofurantointrimethoprimmethenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07202949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07202949.